Atara Biotherapeutics (ATRA) Gross Profit (2022 - 2026)
Atara Biotherapeutics (ATRA) recorded Gross Profit of $439,000 in Q2 2026, down 97.4% from $17.02 million a year earlier but up 12.0% from the prior quarter.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) Gross Profit (2022 - 2026) Analysis & Trends
On a TTM basis, Atara Biotherapeutics' Gross Profit came in at $5.66 million as of Jun 30, 2026, down 96.3% year-over-year; for FY2025, it was $99.56 million, down 7.8% from FY2024.
- Annual Gross Profit has a three-year compound annual growth rate of 16.1% (FY2022 to FY2025).
- Across earlier years, Gross Profit came in at $107.93 million in FY2024, -$313,000 in FY2023 and $63.6 million in FY2022.
- Quarterly Gross Profit has ranged from -$1.94 million in Q2 2023 to $77.71 million in Q1 2025 over the past five years.
- On a year-over-year basis, Gross Profit has declined for five consecutive quarters, with an average decline of 34.0% over the last six quarters.
- Peak year-over-year performance for Gross Profit in the last five years was growth of 340.3% in Q4 2023, against a decline of 99.5% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $392,000 (Q1 2026), $1.49 million (Q4 2025) and $3.34 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Atara Biotherapeutics | 142.51 Mn | 132.61 Mn | 439,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 439,000.00 |
| Mar 31, 2026 | 392,000.00 |
| Dec 31, 2025 | 1.49 Mn |
| Sep 30, 2025 | 3.34 Mn |
| Jun 30, 2025 | 17.02 Mn |
| Mar 31, 2025 | 77.71 Mn |
| Dec 31, 2024 | 25.96 Mn |
| Sep 30, 2024 | 32.59 Mn |
| Jun 30, 2024 | 24.01 Mn |
| Mar 31, 2024 | 25.37 Mn |
| Dec 31, 2023 | 1.09 Mn |
| Sep 30, 2023 | -477,000.00 |
| Jun 30, 2023 | -1.94 Mn |
| Mar 31, 2023 | 1.01 Mn |
| Dec 31, 2022 | 248,000.00 |
| Sep 30, 2022 | 4.46 Mn |
| Jun 30, 2022 | 51.58 Mn |
| Mar 31, 2022 | 7.31 Mn |
API Access
Atara Biotherapeutics Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=ATRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();